Podcasts about type1

In today's episode, we sit down with Dr. Jody Stanislaw to discuss the relationship between sugar, blood glucose, and Type 1 diabetes. Diagnosed with Type 1 diabetes at just seven years old, Dr. Stanislaw has spent more than four decades living with the condition and over a decade helping others better understand how to manage it. Now, she combines personal experience with professional expertise to offer a practical perspective on diabetes care that emphasizes education, lifestyle, and informed decision-making. Dr. Stanislaw is a naturopathic physician, Certified Diabetes Educator, Type 1 Diabetes Specialist, and founding board member of the Low Carb Diabetes Association. Through her virtual practice, she works with individuals around the world to improve blood sugar management while addressing the broader lifestyle factors that influence long-term health. Hit play to learn about: Common misconceptions about sugar and Type 1 diabetes. Practical strategies for improving blood sugar management. The role of nutrition in supporting metabolic health. Why lifestyle habits matter alongside insulin therapy. Dr. Stanislaw earned her Doctorate in Naturopathic Medicine in 2007 and has become a leading educator in the Type 1 diabetes community. Her TEDx Talk, Sugar Is Not a Treat, has been viewed more than five million times, helping raise awareness about diabetes management and the impact of nutrition on overall health. Connect with Dr. Stanislaw: Personal Website Buy Hunger: An Adventurous Journey of Finding Peace Within Tedx Talk Facebook Instagram X Youtube

On this bonus episode of Diabetes Connections... we're talking about a fascinating new partnership between Omnipod and Calm – the meditation app, designed specifically for people with type 1 diabetes. Calm says it helps people sleep more, stress less and live mindful.. what does that look like for our community? I'm talking to advocate Meg Cremins, a Calm user who lives with type 1 and got to check out the collaboration, about what it sounds like, who it helps, and her thoughts on why caring for your mental health isn't really separate from diabetes care. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at Moms' Night Out this fall (and check out our 2027 cities)! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

I love when I get to learn from fellow Enneagram coaches and hear about their real-world experiences and fresh takes.In this episode, I had the opportunity to sit down with Lee Fields and Seth "Creek" Creekmore, co-founders of Analog Enneagram, to discuss the coworker chemistry between the Enneagram Type 1 (Striving to Feel Perfect) and Type 4 (Striving to Feel Unique).Lee is a certified Enneagram coach and teacher who serves as VP of the IEA Southeast chapter and on faculty with Awareness to Action. Creek is a coach, musician, and podcast producer behind Fathoms, the Awareness to Action Podcast, and the IEA's podcast. Together they bring serious depth to this framework, and honestly, this was one of the most thoughtful, insight-packed conversations I've had on the show.Lee represented the One, Creek represented the Four, and what unfolded was a refreshing, honest, funny, and real-life look at how these two types show up in working relationships and on teams; from the quiet trust-building in the beginning of a One-Four dynamic, to the friction points around identity and rigidity, to the surprising gifts each type brings when they're working well together.If you work with a One or a Four, lead one, or are one yourself, this episode will give you language for dynamics you've probably felt but never quite named.Connect with Lee & Creek:

Join Pam for this very important episode as she speaks with Farah Dahabi, a Clinical Social Worker and Director at LightHouse Arabia, who specializes in grief, trauma, and health psychology. During their discussion, they unpack the trauma a parent goes through when their child is diagnosed with Type 1 Diabetes. Farah also shares strategies to help caretakers cope with the stress and anxiety of managing a chronic condition like Type 1 Diabetes in a child.   Join the Diapoint mailing list for exclusive insights, offers and diabetes wisdom. You can also find free resources, blogs and articles about health, wellness, and diabetes at www.diapointme.com or visit the Diapoint Shop at www.diapointshop.com for beautiful diabetes and health accessories.   If you're enjoying this podcast, we'd love to hear from you! Your feedback helps us create content that serves you better. So, if you have a moment, please head over to Apple Podcasts— Spotify or wherever you listen to your podcasts—and give us a rating and review. Five-star ratings really help us reach more listeners.   Don't forget to hit the 'Subscribe' button so you never miss an episode. And if any of our episodes or guests resonate with you, share them on social media or forward them to friends and family who would benefit from our community's collective wisdom.   Visit the Diapoint Shop, where we offer beautiful, practical diabetes supplies and lifestyle accessories.   The Ultimate T1D Game Plan: A game-changing home study program for parents of school-aged children with Type 1 Diabetes.   Are you a healthcare provider or coach who wishes to coach your clients or have more meaningful conversations with your diabetes patients? Check out How to Coach People With Diabetes at www.diapointlearning.com   Diabetes resources.   Looking for health support? Set up a FREE Health Plan call today! Book a time to meet with Pam at this link.   You can also watch our podcast episodes and more on our YouTube Channel! @DiapointTV   Connect with Diapoint @diapointme: Instagram | Facebook | Twitter | Pinterest   Connect with Diapoint Arabia in Arabic: Instagram | Facebook | DiapointArabia.com   Find episodes, show notes, and guest info for all Dia-Logue episodes on the Diapoint website.   Would you like to sponsor our podcast? Get in touch: info@diapointme.com   For more information and full details of our work, visit diapointme.com. Subscribe to the podcast so you get notifications for all our episodes, and please share it on social media or with anyone you think could benefit from this free content. Thank you for listening!

We get into the emotional side of raising a child with type 1 diabetes: the pressure to be perfect, the guilt that social media can create, and the way so many parents slowly lose themselves after diagnosis without even realizing it. We do "check-ins" at our mom's night Out events where you can ask any question of a diabetes expert. I thought it would be helpful to bring those questions and answers to you here. My guest is Abby Cooper, mom of a child with T1D and Risely Health diabetes coach.. who was one of our check in experts this year. We talk about independence, middle school, camp, and what happens when your entire identity starts revolving around your child's diagnosis. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at Mom's Night Out this fall in Detroit and Seattle. Use promo code FFL to save (valid until 7/19) Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

What can 21 days of continuous glucose and ketone data, recorded during a 1,000-mile cycling journey, reveal about managing type 1 diabetes on a ketogenic diet?Dr. Ian Lake is a UK-based primary care physician who has lived with type 1 diabetes for more than 30 years. After two decades of conventional high-carbohydrate management, he adopted a very low-carbohydrate, ketogenic approach and began examining insulin not simply as a glucose-lowering medication, but as a metabolic hormone whose requirements are influenced by nutrition, exercise, sleep, circadian rhythm, hydration, and stress. His new book, Shifting Gears, documents the ride and the lessons he took from it.Dr. Lake treated the journey as a 21-day personal experiment, wearing continuous glucose and ketone monitors while consuming roughly 20 grams of carbohydrate per day. In this conversation with Dr. Dominic D'Agostino, he shares what his data showed: an average ketone level near 1.2 mmol/L, daily insulin requirements declining from the mid-20s of units to around 16, and an episode in which glucose and ketones rose together after he had taken too little insulin.Dr. Lake describes how, in his case, one unit of insulin brought his ketones from approximately 3.0 to 0.9 mmol/L within about 20 minutes. He and Dr. D'Agostino use the experience to explore the distinction between nutritional ketosis and diabetic ketoacidosis, the essential role of adequate insulin, and why ketone readings must always be interpreted alongside glucose levels and clinical context.They also discuss insulin sensitivity during prolonged exercise, the practical challenges of adjusting insulin during endurance activity, and research suggesting that fat-adapted athletes may sustain high rates of fat oxidation at relatively high exercise intensities.Questions Answered in This EpisodeWhat did 21 days of continuous glucose and ketone monitoring reveal during a ketogenic, 1,000-mile cycling journey?How did prolonged endurance exercise affect Dr. Lake's daily insulin requirements?How is nutritional ketosis different from diabetic ketoacidosis, and what role does insufficient insulin play in DKA risk?What did Dr. Lake observe when his glucose and ketones began rising at the same time?How might fat adaptation influence fuel use and endurance performance?What are the practical limitations of continuous glucose and ketone monitoring for real-time insulin decisions?This conversation offers a rare look at 21 consecutive days of glucose, ketone, insulin, nutrition, and exercise data, while also emphasizing that Dr. Lake's experience is an individual case, not a substitute for personalized medical supervision.More Links:Shifting Gears, Dr. Lake's book, on AmazonType1Keto, Dr. Lake's site featuring the book and the Zero Five 100 projectSpecial thanks to the sponsors of this episode:✅ Zocdoc: Find and instantly book a top-rated doctor here.✅ fatty15: Get an additional 50% off a 90-day subscription starter kit with code METABOLICLINK.✅ Toups and Co: Get 25% off your first order with code METABOLIC.In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in!You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel!Find us on social: InstagramFacebookYouTubeLinkedInPlease keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by Raquel Baron, founder of Type One Together, to discuss the challenges, triumphs, and everyday realities of raising a child with type 1 diabetes. Diagnosed herself at age five, Raquel combines her lived experience with years of supporting families through Type One Together, an organization that provides trusted resources, educational programs, and a nationwide network of trained babysitters for children with type 1 diabetes. Together, Dr. Edelman and Raquel explore the emotional side of diabetes that often goes beyond blood sugars. They discuss helping children navigate school, sports, friendships, burnout, and growing independence, while giving parents practical strategies to reduce fear, build confidence, and create a healthier relationship with diabetes. The conversation also covers diabetes technology, social media, Afrezza for children, community support, and why perfection should never be the goal.Whether you're the parent of a newly diagnosed child or have been managing type 1 diabetes for years, this episode offers practical advice, reassurance, and reminders that children with diabetes can live full, active lives.✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

 I ate two carb-heavy lunches... and my blood sugars stayed nearly flat. The secret wasn't taking more insulin—it was understanding how activity and insulin sensitivity work together.If you've ever wondered how exercise affects your blood sugars (and how to use it to your advantage), this video is for you. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

Clement Manyathela speaks to registered dietician Laura Mostert about recognising the warning signs of Type 1 diabetes in children, why early diagnosis is critical, and how families can successfully manage the condition while helping children live healthy, active lives. The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

We got a question in for our American Mamas, Teri Netterville and Kimberly Burleson...Dear Mamas, have you heard about the difference between type one and type two kinds of fun?If you'd like to ask our American Mamas a question, go to our website, AmericanGroundRadio.com/mamas and click on the Ask the Mamas button.

In this episode, Professor Clare Collins interviews Rebecca Flavel, a pediatric dietitian and credentialled diabetes educator, about what matters most for good blood sugar control? protein, fat or carbohydrate? They discuss advances in diabetes care related to modern insulin pumps and continuous glucose monitors (CGMs) that provide real-time data to help improve blood sugar control, including time-in-range. They cover practical tips for families helping their children and adolescent with managing type 1 diabetes, including education on how fat and protein also affect blood glucose. Regular engagement with healthcare teams specialising in diabetes management helps empower people living with type 1 diabetes, and their families, to adapt to varying food and insulin needs over time.Key topicsAdvancements in insulin technology and devicesThe role of continuous glucose monitoring (CGM)Impact of diet, fat, and protein on blood sugar levelsChallenges and solutions in managing pediatric diabetesImportance of regular reviews and personalized care plansKeywords: #diabetesmanagement, #insulintechnology, #continuousglucosemonitoring, #pediatricdiabetes, #bloodsugarcontrol, #diabeteseducation, #insulinpumps, #diabetestechnology, #type1diabetes, #diabetescareDiabetes Australia - https://www.diabetesaustralia.com.au/Children's Hospital Perth - https://www.cha.health.wa.gov.au/To access the Healthy Eating Quiz: Click on the top right hand 'green button' called 'How healthy is my diet' https://nomoneynotime.com.au/Want a more Personalised Food, Nutrient Assessment Report? Use our Australian Eating Survey - For a 50% discount enter the 'DietCheck' code at the checkout! Purchase here https://australianeatingsurvey.com.au/Are you in a position to make donation to support our No Money No Time website? Donate hereHere's the link to the No Money No Time closed Facebook group (be sure to take the Healthy Eating Quiz first) https://www.facebook.com/groups/386824626838448Our No Money No Time email: nmnt@newcastle.edu.au and our Nutrition Science Bites email: nutritionsciencebites@newcastle.edu.au Are you in a position to make donation to support our No Money No Time website? Donate here Hosted on Acast. See acast.com/privacy for more information.

Richie Brave discusses UK drill with music commentator Sillah, as well as type 1 diabetes with content creator Lydia Brian. @1Xtra on socialProduced by Unedited for BBC Radio 1Xtra.

In today's episode, the conversation leads into something Ken feels deeply — the frustration of hearing people claim that Type 1 diabetes can be cured. As an autoimmune condition, Type 1 operates differently than Type 2, and the constant lumping together of both conditions by researchers, politicians, and the media creates real harm for people navigating the daily reality of living insulin dependent. Ken makes the case for why the principles of good health apply to everyone — but the mechanisms, and especially the medication piece, are not the same.Then the episode shifts into one of the most practical conversations Ken and Graham have had — the real tradeoffs between wearing a CGM and going without one. Graham has chosen to step away from CGM and rely on finger sticks and MDI, and Ken respects that. But he also gets honest about what that choice means when it comes to getting meaningful support from your endocrinologist. Without continuous data, your doctor is working with a handful of snapshots. With it, they can see the full picture — and that changes everything about the quality of care you can receive.

Melissa Slemp has lived with type 1 diabetes for 44 years — since she was diagnosed in 1982, before glucometers, before CGMs, back when insulin came from vials and syringes and "boiling your needles" was still a recent memory for a lot of people. In this episode, we trace that whole arc: what early management actually looked like, the high-risk pregnancy she navigated in the 90s, and the moment — after more than four decades on injections — she finally switched to a pump. If you've ever wondered what it's like to hand over that much control after that much time, this is the conversation. But the real heart of this episode is what happens to blood sugar when a woman with type 1 diabetes hits perimenopause. Melissa walks through her own experience of watching her basal insulin needs climb for no obvious reason, the years she spent without an explanation, and what she eventually learned about estrogen, progesterone, and insulin resistance — knowledge she says she had to dig up herself, because most endocrinologists and OBGYNs simply aren't trained in the overlap. That research became the reason she wrote Highs, Lows, and Hormones, a survival guide for women navigating diabetes from their monthly cycle through menopause. Along the way, we get into hormone replacement therapy, why so many women blame themselves before they ever think to blame their hormones, and the bigger pattern underneath it all: how much of diabetes research and care has historically centered men, and what it costs women when it does. There's also a genuinely great story about how Melissa met her husband, who also lives with type 1 — on the side of the road, of all places. This one's for anyone managing type 1 diabetes as a woman, anyone who loves someone who is, or anyone who's ever felt like their body changed the rules without telling them why. Chapters: 00:00 Cold open and introducing Melissa Slemp 01:21 Welcome, and 44 years living with type 1 diabetes 02:24 Diagnosed in 1982, before glucometers existed 04:03 Reframing: the best and hardest time to have diabetes 04:59 Growing up rural with limited access to healthcare 07:09 Early management: injections, mixed insulin, urine strips 07:46 A high-risk pregnancy in the 90s 08:13 Switching to a pump after 40+ years on injections 10:24 How Melissa met her husband, also living with T1D 13:06 Introducing the hormone and diabetes connection 20:14 Rising basal needs and insulin resistance in perimenopause 25:25 Community stories and menopause's hidden career toll 29:44 The gender gap in diabetes research 33:04 Hormones, GLP-1s, and insulin as hormone therapy 36:03 Advocating for yourself with doctors and specialists Resources: Melissa's Book: Highs, Lows, & Hormones: A Survival Guide for Women With Diabetes From Monthly Cycles to Menopause The Menopause Society Type 1 In Midlife Podcast

Every person with Type 1 diabetes has a date that changed their life forever. Ken and Graham get into whether we should celebrate it, fear it, or somewhere in between — and what your answer says about your relationship with this condition.It started with a simple question — do you know your diaversary?For Ken it's sometime in late June. For Graham it's around February 15th, the same month his family company was founded and named after him. But beyond the dates themselves, the question opened up one of the most honest conversations Ken and Graham have had about what it actually means to live with Type 1 diabetes for decades.Should we celebrate our diaversaries? Is it healthy to mark the day your life changed forever — or does it keep us tethered to a moment that's better left behind? Ken and Graham explore both sides of that coin and land somewhere that will resonate with anyone who has spent years navigating the emotional complexity of this condition.From there the conversation moves into one of the biggest questions in the Type 1 community — will there ever be a cure? Ken shares his honest perspective on what focusing on a cure does to your mental state, why he chooses to live in the present rather than wait for a finish line that may or may not come, and why that mindset shift is one of the most powerful things a person with diabetes can make.This one is equal parts honest, emotional, and grounding. It's exactly what the diabetes community needs to hear.

Message Home Trails here - include an email or name for a response ⬅️On this weeks podcast we speak to Chris Cope.Chris is a father, GP and type 1 diabetic that is on a roll of crushing Spine Race course records. He recently took nearly 90 minutes off the Challenger South CR, to add to his repertoire of stunning wins at the Spine, from Sprint South to the full summer race.After a difficult DNF in January on the full winter race, Chris was back for redemption at the summer race.In this episode we talk about his Superhero origin story, his work as a doctor and how his family are following his footsteps in endurance sport. We also talk at length about his diabetes and how his continuous glucose monitor and insulin pump are both an advantage/disadvantage when it comes to ultramarathon running!We also briefly talk about his recent double Bob Graham round that sadly ended after a short distance due to a heart condition that momentarily returned to put a stop to his big day out!Chris is a great guy and it was a pleasure to finally get him on the podcast!HT@ultrarunning_sam@hometrails_http://www.youtube.com/@ultrarunningsam

There is a fundamental link between diabetes and kidney care. But while there are many medications available to improve CKD outcomes in people with type 2 diabetes, the same options are not available for people with type 1. In this special episode, Dr. Neil Skolnik speaks with Janet McGill, MD, MA, FACE, FACP about the underdiscussed prevalence of CKD in type 1 and the importance of continued development in this area. This special episode is sponsored with support from Bayer. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Janet B. McGill, MD, MA, FACE, FACP, Professor of Medicine at the University of Washington's John T. Milliken Department of Medicine, Division of Endocrinology, Metabolism, and Lipid Research Selected References: Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026. The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1):S246–S260 Finerenone in Type 1 Diabetes and Chronic Kidney Disease. N Engl J Med 2026;394:947-957 Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 2020;383:2219-2229 Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 2020;383:1436-1446 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med 2024;391:109-121

Anxiety with type 1 diabetes isn't always about low blood sugars... it's often about the uncertainty of what might happen.The goal isn't to eliminate fear—it's to build enough certainty that fear no longer controls your decisions.If dosing anxiety has been holding you back, this message is for you.

Diabetes technology is evolving faster than most people realize — and Ken and Graham break down exactly what that means for your day-to-day management. Plus, Ken closes with something every person living with diabetes needs to hear right now.

Guest: Julianne LallyShow Notes:Type 1 diabetes doesn't start with symptoms, it starts silently. In this episode, early screening expert Julianne Lally reveals how autoantibody testing can detect risk years before diagnosis and why that window matters. Learn how early detection can reduce complications, what families should know about screening access, and how new innovations are working to make early screening the norm, not the exception.Guest Bio:Julianne Lally, DMSc, MHS, PA-C, is Associate Director of Medical Affairs at Breakthrough T1D. She focuses primarily on screening and early detection of type 1 diabetes, leads the Early Detection Pilot Program and facilitates healthcare professional education efforts. Julianne's professional interest in T1D stems directly from her own personal diagnosis at age twelve. Doctorate of Medical Science, Masters of Health Science, and Physician AssistantQuote:“It's really beautiful to think about a future where people are diagnosed in their doctor's office and not in the hospital or ICU.”Question of the Day:If you have a family history of autoimmune conditions, type 1 diabetes in particular. Have you ever considered screening for type 1 diabetes? Why or why not?On This Episode You Will Learn:Why early detection of type 1 diabetes is so important.How type 1 diabetes can be detected before symptoms develop..Common symptoms families should watch forHow screening for type 1 diabetes worksNew research and treatments that could delay or prevent the disease.Connect with Yumlish!Yumlish Website: YumlishYumlish on Instagram: @yumlish_Yumlish on Facebook: YumlishYumlish on Twitter: @yumlish_Yumlish on LinkedIn: YumlishConnect with Julianne Lally!Website URL: Type 1 Diabetes Screening & Early DetectionInstagram URL: @BreakthroughT1DFacebook URL: Breakthrough T1D Twitter(X) URL: @BreakthroughT1DLinkedIn URL: linkedin.com/in/juliannemlally/

Check out this week's Coworker Compatibility episode between the Type 1 (striving to feel perfect) and the Type 8 (striving to feel powerful). When you tune in, you'll hear about:the strengths of this duo at work potential friction points communication styles of each leadership vs. direct report dynamics of each growth opportunities in the workplaceResources + Links:Learn more about the 3-part Dream Team Momentum program: enneagrammba.com/enneagram-team-workshopsRun your own Enneagram Workshop: enneagrammba.com/enneagram-workshop-kitConnect with Sarah on LinkedIn: linkedin.com/in/sarahlynnwallace/Take the 2-question Enneagram quiz: enneagrammba.com/blog/enneagramtestWork with Sarah - workshops, speaking, and team facilitation: enneagrammba.com/enneagram-speakerHave a request for a future episode? Drop a text here! 

From 70% to 95–100% Time in Range.

It's In the News - a look at the top diabetes headlines and stories happening now. Our top stories: More information about type 1 and COVID, including the vaccine, why is the latest GLP-1 medication, not yet FDA approved, showing up all over the place, what table sugar and vinegar could mean for drug costs, a new inhaled insulin study and much more  I'll see you at Friends for Life next week. Come find me at Table T18 Learn more about our in-person events here: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Transcript & links:    Okay.. our top story this week: XX A large Swedish study found that the increased risk of being diagnosed with type 1 diabetes after COVID-19 infection is mostly limited to the first 30 days after infection and does not continue long term. Researchers followed nearly the entire Swedish population under age 80 from 2020 through 2023 and found that while SARS-CoV-2 infection was linked to a temporary rise in new type 1 diabetes diagnoses, the risk declined over time. The study also found no evidence that COVID-19 vaccination increases the long-term risk of developing type 1 diabetes. Vaccination did not significantly change the relationship between COVID-19 infection and diabetes risk, and any small increase in diagnoses seen among adults shortly after a first vaccine dose was not seen after later doses or during longer follow-up. The researchers concluded that their findings do not support changing current COVID-19 vaccination recommendations because of concerns about type 1 diabetes risk. https://www.infectiousdiseaseadvisor.com/news/covid19-infection-may-increase-short-term-type-1-diabetes-risk/ XX Two new studies are challenging the traditional view that type 1 diabetes develops solely because the immune system attacks insulin-producing beta cells. Researchers from Indiana University found evidence that beta cells themselves may play an active role in determining whether they survive or succumb to the stresses that lead to type 1 diabetes. In the first study, scientists discovered that some healthy human beta cells can quickly activate an antiviral defense system when exposed to interferon-alpha, an immune signal often produced during viral infections. This response relies on molecules called reactive oxygen species (ROS), which are usually associated with cell damage but, in this case, appeared to help switch on protective antiviral genes. Researchers found this defense program in healthy cells and in people at risk for type 1 diabetes, but not in beta cells from people who already had the disease. The findings suggest that losing this built-in defense mechanism may make beta cells more vulnerable during the development of type 1 diabetes. The second study focused on autophagy, the process cells use to recycle damaged or worn-out components. Using a new imaging technique, researchers observed that beta cells in a mouse model of type 1 diabetes showed defects in autophagy before blood sugar levels began to rise and even before a full immune attack was underway. This suggests that problems inside the beta cells may occur early in the disease process rather than being caused entirely by the immune system. Together, the studies point to a more complex picture of type 1 diabetes. While they do not show that beta-cell defects cause the disease, they suggest that differences in how beta cells respond to stress, viral signals, and cellular damage may influence who develops type 1 diabetes and how the disease progresses. https://medicalxpress.com/news/2026-06-beta-cells-players-diabetes.html XX Researchers have created the most detailed map yet of how the human pancreas develops during childhood, offering new clues about why children are especially vulnerable to developing diabetes. The study, published in Nature Communications, examined pancreatic tissue from 123 children without diabetes, ranging from newborns through age 10. Using advanced imaging techniques, scientists tracked how insulin-producing islet cells grow and mature during the first decade of life. The researchers found that pancreas size varies dramatically at birth, with some infants having pancreases nearly four times larger than others. They also discovered that insulin-producing beta cells grow more slowly after birth than previously thought, suggesting that much of a person's lifelong beta cell capacity may be established before birth and during early childhood. Other findings showed that insulin-producing cells mature earlier than glucagon-producing cells and that new hormone-producing cells may continue to form after birth. The researchers hope this new understanding of pancreas development will help scientists identify diabetes risk earlier and develop better strategies for prevention and treatment in children. https://news.vumc.org/2026/06/29/unlocking-diabetes-secrets-pediatric-organ-donors-help-map-a-path-to-a-cure-and-prevention/   XX At the American Diabetes Association annual meeting, 2-year results from the SUPPRESS-EARLY trial showed that initiating tirzepatide (Mounjaro, Zepbound) early in the course of type 2 diabetes led to substantially higher rates of near-normal glycemic control and also led to broader metabolic improvements compared with intensive conventional therapy.   In this MedPage Today video, investigator Stefano Del Prato, MD, of the University of Pisa in Italy, discusses the findings.     Following is a transcript of his remarks:   What happened is that in the tirzepatide-treated arm, 85% of the population at the end of the second year was on the maximum dose of tirzepatide 15 mg. And then the remaining 15 with the different doses.   Interestingly, in the population that had been treated with the intensive conventional approach, 85% of them ended up to have, on top of metformin, a GLP-1 receptor agonist, mainly represented by subcutaneous semaglutide [Ozempic, Wegovy], 60+%, another 15% on oral semaglutide [Rybelsus], and the remaining on dulaglutide [Trulicity].   And I have to say that maybe the recommendation to really push along the line to try to achieve and to strive to achieve [glycemic] control was successful in these individuals. Because the population that had been recruited in the study started off with a baseline A1C of 7.8% and it went down to 6.3% in the conventionally intensive treatment, which is not bad at all, on average is below the target of 6.5%.     However, when we look at the effect of tirzepatide, the final level of A1C at the end of the second year was 5.6%, which is on average below the upper limit of the normal range for A1C, 5.7%. This also translates into more people not only achieving normal glycemia, if we can define normal glycemia as A1C below 5.7%, greater than what we observed in conventionally treated individuals. So it was around three times more people achieving an A1C of 5.7%, in the range of around 65%, as compared to 28% with people on a conventional optimized treatment.   Now, this is not surprising knowing the potency of tirzepatide. But again, going back to the rationale of the design, can we change what is the natural history of the disease? This seems to be at least of interest and it's possibly changing the trajectory of the disease for glycemic control, as I mentioned, but also in terms of the body weight and waist circumference because both body weight and waist circumference went much lower with tirzepatide compared to the conventional treatment.   Tirzepatide also was associated with an improvement in the lipid profile, in particular with the LDL, triglycerides, and the triglyceride concentration and non-HDL cholesterol, and also with a statistically significantly lower systolic blood pressure with a numerical reduction in the diastolic blood pressure.   And also the other thing that probably will ... become more apparent with the study continuing is that the investigators were allowed to add on any other treatment ... needed to achieve their target. So tirzepatide was just metformin and tirzepatide. In the control group, there was already 10% of people who were receiving two drugs on top of the metformin.   So another potential result of the trial is that it's possible to achieve and maintain better glycemic or better metabolic control over the time without really needing to increase the number of medications in order to achieve that goal. And we know that type 2 diabetes is a progressive condition often requiring intensification of the treatment.   So these initial results really stand for a great opportunity with tirzepatide. Of course, we need to wait for the 4 years just to confirm that this is indeed the case, but the initial result seems to point along that line. https://www.medpagetoday.com/meetingcoverage/adavideopearls/121967 XX A study from the University of Virginia found that high blood pressure is extremely common among people with diabetes, even among those who believe their blood pressure is under control. Researchers measured blood pressure in 172 adults with type 1 or type 2 diabetes during routine eye clinic visits and found that only 8% had normal readings. About half had stage 2 hypertension, and more than 10% had blood pressure levels high enough to be considered a medical emergency. The study also revealed that many patients were unaware of how serious their blood pressure problems were. Among those who thought their hypertension was well controlled, more than half still had stage 2 hypertension. Nearly 60% of participants were advised to contact their primary care provider, and one patient required an emergency department referral. Most patients supported blood pressure screening during eye exams, leading researchers to suggest that routine blood pressure checks in ophthalmology clinics could help identify undiagnosed or poorly controlled hypertension before it leads to serious complications such as heart attack, stroke, or worsening diabetic eye disease. https://medicalxpress.com/news/2026-06-routine-eye-exams-reveal-stage.html XX What is going on with retatrutide? This is the next generation GLP-1 but it's not authorized outside of clinical trials. Big investigation by CBS shows retatrutide is for sale all over the internet, a phenomenon they say has no modern precedent. CBS News identified more than 120 websites selling or promoting retatrutide, including more than 50 clinics staffed by licensed medical professionals. After being contacted by CBS News, at least 21 clinics abruptly removed retatrutide from their websites or changed the language to state they don't offer it. Others defended prescribing it, saying they're confident enough in results from clinical trials sponsored by drugmaker Eli Lilly that they didn't need to wait for the FDA's independent, rigorous review. An FDA spokesperson said retatrutide "has not been found safe or effective for any condition," adding that it "cannot be manufactured or distributed except for investigational use." The Justice Department is prosecuting two cases – in Utah and Florida – involving the sale and prescription of retatrutide. But the first line of enforcement is often at the state level. Ohio's Board of Pharmacy has taken action against several pharmacies and clinics providing retatrutide, and just last month, Alabama's Medical Board warned physicians against prescribing research-grade medications. The FDA has sent 14 warning letters to companies that have advertised retatrutide since 2024. Of these, at least six have continued to offer it online, including a business called Pink Pony Peptides. A TikTok account associated with the firm responded to the warning in April by taunting the FDA, boasting that the business "just had the best 24 hours ever." In May, Eli Lilly announced that participants in a large clinical trial taking the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks. Side effects – including nausea, diarrhea, constipation and vomiting – were comparable to similar therapies, the company said. "Anyone purporting to sell retatrutide to consumers is breaking the law," an Eli Lilly spokesperson said https://www.cbsnews.com/projects/2026/experimental-weight-loss-drug/ XX Pioneering research has developed a new way of creating carbohydrate-based medicines, which could ultimately replace costly drugs for common health conditions, using two cheap basic ingredients – table sugar and vinegar. These medications include SGLT2 inhibitors, widely prescribed drugs used to treat type 2 diabetes, heart failure and chronic kidney disease. Co-lead author Professor Phil Baran, Dr. Richard A. Lerner Endowed Chair at Scripps Research, in San Diego, California, said: "The point of this is to show that anyone in a garage can make an SGLT2 inhibitor with reagents that are widely available. We have not patented this method, so we welcome any generic drug company – or anyone else – who wants to use it to help bring costs down for patients." https://www.newswise.com/articles/new-study-shows-table-sugar-could-hold-a-cheaper-quicker-key-to-making-vital-drugs-for-diabetes-heart-failure-and-chronic-kidney-disease XX England and Wales approve teplizumab to slow progression of T1D. At the moment, the Scottish Medicines Consortium does not have an appraisal of Tzield on the go, so, there is likely to be a disparity in access within the UK for the time being. In Northern Ireland, access will depend on a review and adoption of NICE guidance.  Sanofi is expecting to see an uptick in momentum thanks to two subsequent FDA approvals, one in children as young as one with stage 2 T1D, and a second to delay the decline in endogenous insulin production in children aged eight to 17 years recently diagnosed with stage 3 T1D. btw you might here more people referring to stage 4 diabetes. They've added that to include people diagnosed with type 1 who've been on insulin for a longer period of time – basically long enough to not be eligible for the current guidelines for Tzield. https://www.bbc.com/news/articles/ce8mzd94r76oXX XX Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of Care in Overweight and Obesity, "Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults," published in Diabetes, Obesity, and CardioMetabolic CARE® and BMJ Open Diabetes Research & Care.  Key highlights of the guidance: Early screening: Annual BMI screening with emphasis on tracking weight trends to identify risk earlier, including a longitudinal life-event weight graph tool for standardized assessment. Enhanced diagnosis: Combines BMI with waist measurements and population-specific thresholds to improve accuracy. Notably, the guidelines recommend that BMI in the overweight range together with central adiposity measurements warrant a formal obesity diagnosis. Comprehensive evaluation: Holistic assessment including medical, behavioral, and social factors. Offers a fully integrated obesity diagnostic algorithm. Risk stratification: Use of tools like the Edmonton Obesity Staging System to guide care. Chronic care approach: Ongoing monitoring and follow-up to support long-term management. Reducing bias: Promotes person-centered, non-stigmatizing care and system-level improvements at the clinical workflow level and encourages screening for prior weight bias/stigma experiences. https://www.prnewswire.com/news-releases/new-standards-of-care-in-overweight-and-obesity-section-screening-diagnosis-evaluation-and-staging-of-obesity-in-adults-302809670.html XX Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. Dexcom said its reimagined app aims to make glucose insights easier to understand and act on. It hopes to help build awareness of how food, activity, sleep and stress influence overall wellbeing.   The company also reiterated plans to launch Stelo internationally. It expects to bring the sensor to the UK, Australia, New Zealand and South Korea later this year, continuing into 2027. https://www.drugdeliverybusiness.com/dexcom-launches-enhanced-stelo-app/ XX MannKind Corporation recently announced it received a grant from Breakthrough T1D to support the INHALE-1 clinical study of Afrezza, its ultra rapid-acting inhaled insulin, in newly diagnosed pediatric type 1 diabetes patients aged 10 to under 18 years. This external funding for a trial focused on early use of Afrezza in children highlights growing third-party support for inhaled insulin in pediatric diabetes care. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnkd/mannkind/news/afrezza-pediatric-trial-grant-might-change-the-case-for-inve XX Alexander Zverev heads into Wimbledon with plenty of momentum. The French Open champion returns to the All England Club looking to build on his first Grand Slam title and gain ground on Carlos Alcaraz in the race for the No. 2 spot in the ATP rankings. Zverev has an opportunity to make up points quickly after a first-round exit at Wimbledon last year. But his final tune-up before Wimbledon came with an unexpected challenge. During his semifinal loss to Taylor Fritz at the Halle Open, Zverev said a malfunctioning glucose sensor led to serious diabetes management issues on court. The sensor incorrectly showed his blood sugar was high when it was actually low, causing him to take more insulin than needed. "I had huge problems with the sugar because the sensor I use gave me a completely incorrect reading," Zverev said after the match. "During the match, or rather during the first 45 minutes, I had to consume about 350 grams of sugar. I felt absolutely terrible." Despite feeling unwell, Zverev pushed the match to three sets before falling 6-7(4), 6-4, 7-5 to Fritz. He credited his opponent with playing the better match and said the diabetes-related issue was not an excuse for the result. Zverev, who was diagnosed with type 1 diabetes at age 4, uses Medtronic diabetes technology to help manage his glucose levels while competing on the ATP Tour. He said the sensor error was the first major problem he has experienced after nearly a decade of using the technology. The German said the incident should not affect his Wimbledon preparations. With the sensor issue behind him, Zverev will begin his Wimbledon campaign focused on adding another strong result to what has already been a breakthrough season.   https://www.reuters.com/sports/tennis/zverev-says-glucose-sensor-malfunction-affected-halle-semi-final-loss-fritz-2026-06-21/

A new immunotherapy drug doesn't cure type 1 diabetes, but for people identified in the very earliest stage of the disease, it can delay the need for insulin by an average of almost three years. Does overpraising kids create more harm than good? How's your netiquette? Yes, internet etiquette. And university acceptance rates are falling, but why?See omnystudio.com/listener for privacy information.

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by pediatric endocrinologist Dr. Anna Cymbaluk, along with Philip and his father Jim, to discuss the recent FDA approval of Afrezza inhaled insulin for children and adolescents living with type 1 diabetes. Dr. Cymbaluk served as an investigator on the INHALE-1 trial, while Philip participated in the study himself, providing a unique real-world perspective on what it is like to transition from injections to inhaled insulin, and Philip's dad, Jim provided the parent perspective as well as addressed parental concerns that might have arisen.The conversation focuses on the INHALE-1 study and the unmet challenges that continue to exist around mealtime insulin dosing in pediatric diabetes care. Dr. Cymbaluk reviews the trial design, glucose outcomes, safety data, patient satisfaction findings, and the practical realities of introducing inhaled insulin into everyday diabetes management. Philip and Jim share how Afrezza impacted school, sports, social situations, and the day-to-day burden of diabetes, particularly around pre-bolusing, corrections, and avoiding multiple injections throughout the day.Dr. Edelman and Dr. Cymbaluk also explore how Afrezza is dosed, how inhaled insulin differs from injected insulin, who may be a good candidate, and where it may fit alongside pumps and automated insulin delivery (AID) systems. For families looking for more flexibility, fewer mealtime barriers, and another option in the diabetes toolbox, this episode provides an honest look at the benefits, limitations, and real-world experience of inhaled insulin in children and teens.Key Topics• The FDA approval of Afrezza for children and adolescents living with type 1 diabetes• The design and results of the INHALE-1 pediatric clinical trial• Patient satisfaction and quality-of-life outcomes from the study• The challenges of pre-bolusing and mealtime insulin management in children and teens• How inhaled insulin compares to traditional mealtime injections• Dosing strategies, cartridge sizes, and insulin conversion considerations• Using Afrezza for corrections, meals, and post-meal dosing• The role of continuous glucose monitoring (CGM) when using inhaled insulin• Safety findings, lung-function monitoring, and cough management• Who may be a good candidate for Afrezza—and who may not be• Benefits for active children, athletes, and those participating in sports• Social situations, injection avoidance, and reducing the burden of diabetes management• Using Afrezza alongside insulin pumps and automated insulin delivery (AID) systems• The importance of having more treatment options to individualize diabetes careSupported by an unrestricted educational grant from MannKind CorporationSubscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram: / tcoydFacebook: / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

We start the pod with a poo story and end it with one. Really hitting peak podcasting performance lol!

Alex Tolwinski… known online as @TypeOneAlexx… built a pretty recognizable T1D presence on social media by doing what everyone told him he couldn't do: feasting on Crumble cookies, Chinese buffets, and dirty sodas, and posting every blood sugar along the way. But behind the funny viral videos is a guy who spent years feeling completely alone with his diagnosis, and who eventually found his way back through community.In this episode, Alex joins Lauren to talk about what it actually looks like to live boldly with T1D, why he'll never delete a negative comment, and the moment in college that made him realize he didn't have to figure this out by himself.In this episode you'll hear:Why Alex intentionally ate 6 Crumbl Cookies in one sitting, and what happened to his blood sugar afterwardThe terrifying 24 mg/dL and 28 mg/dL lows that led to paramedics, police officers, and complete memory lossWhat Alex says is the hardest part of Type 1 diabetes (and it's not high blood sugar)How Alex handles the comments that claim he doesn't take care of himselfWhy he answers "what does reclaiming life with T1D mean to you?" with just one wordWHAT'S NEXT:

Type 1 Diabetes can feel like living with invisible thorns.The hard truth? Avoiding the uncomfortable parts—exercise, new foods, insulin adjustments, and learning your body's patterns—doesn't make them disappear. It only lets them keep stealing your freedom.Growth happens when we lean into discomfort, collect data, learn from it, and take action.Don't ask, "Can I do this?"Start asking, "How can I do this?"That's where freedom begins. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

This episode of the PeerDirect Medical News Podcast highlights three major developments shaping diabetes and hematologic oncology care. First, the FDA expanded approval of teplizumab for selected children and adolescents with newly diagnosed Stage 3 type 1 diabetes, making it the first therapy to modify disease progression after diagnosis by preserving beta-cell function. Additional stories review evidence supporting continuous glucose monitoring in basal insulin-treated type 2 diabetes and promising Phase III data showing talquetamab-based bispecific antibody regimens improve outcomes in relapsed or refractory multiple myeloma.

Awakening the Future: How Emerging Narcolepsy Type 1 Therapies Are Redefining Care and Expectations On this episode guest host Steve Kheloussi, PharmD, MBA, FAMCP, principal consultant at Kheloussi Consulting, speaks with Amy Lugo, PharmD, BCPS, BC-ADM, FAPhA, FAMCP, founder and CEO of LoneStar Health Solutions, about the evolving treatment landscape for narcolepsy. The discussion explores the burden of delayed diagnosis, the real-world impact of excessive daytime sleepiness and cataplexy, and how treatment may shift from symptom management toward addressing the underlying disease process. Steve and Amy also examine formulary considerations, patient-reported outcomes, utilization management challenges, and how managed care organizations can balance access, value, and patient-centered care as new therapies enter the market. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Robyn Weisenburger is the very first female helicopter pilot living with type 1 diabetes. This episode is an inspiring journey, and what happens when you don't give up despite the odds. Robyn shares her journey to becoming the very first female helicopter pilot living with type 1, and she gives tips to those who might share her same dream of flying planes with type 1 diabetes. More than anything, her story is one of inspiration and dedication. She proves that whatever your dream, and regardless of the obstacles, one can achieve their dreams as long as they refuse to give up. Links: Robyn's book: Fearless Flight Connect with Robyn on Instagram: @helipilot_robyn   Connect with Taja on Instagram: @tajacato Learn more about Fat Loss for Type 1's   If this episode inspired you in some way, or if you enjoy listening to this podcast, please leave a review and let us know what you loved most. Thank you so much for your support! xo

It's In The News - a look at the top diabetes stories and headlines happening now!   Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: fall Detroit and Seattle.   Okay.. our top story this week: XX The FDA approved Tzield for use in stage 3 T1D – that's what we used to just call type 1. It's the stage where the body can no longer produce enough insulin on its own to manage blood sugars you need to start insulin. This approval is for kids ages 8-17 within 8 weeks of a stage 3 T1D diagnosis. It comes after the PROTECT trial and it's the first approval of a disease-modifying therapy for stage 3 T1D. https://www.prnewswire.com/news-releases/breakthrough-t1d-celebrates-approval-of-tzield-for-use-in-stage-3-type-1-diabetes-in-the-us-302799532.html XX Encouraging results from a small study of islet cell transplantation in people with type 1 where now all 12 participants in the trial are currently living without external insulin after receiving transplanted insulin-producing islet cells.   The study, led by researchers at the University of Chicago, tested an experimental immune therapy called tegoprubart Te-GO-Proo-Bart. The drug is designed to prevent the body from rejecting transplanted cells while avoiding some of the side effects associated with standard anti-rejection medications. You've probably heard about this as the Eledon study – many of the participants have been very active on social media. It was presented at ADA. transplants.https://www.breakthrought1d.org/news-and-updates/tegoprubart-islet-transplant-all-participants-off-external-insulin/ XX New data suggest that acmopatide (ack-MOW-puh-tyd) (CT-868), an experimental once-daily dual GLP-1/GIP receptor agonist, may help people with type 1 diabetes improve blood sugar control, lose weight, and reduce insulin use. Across all doses, participants lost up to 7% of their body weight and reduced insulin use by as much as 15%. The study lasted just 16 weeks, so researchers say longer-term data will be needed to determine whether the benefits can be maintained and whether lower insulin requirements can be achieved without increasing the risk of hypoglycemia. XX A new combination therapy that pairs an amylin analog with semaglutide improved both blood sugar levels and weight loss in several groups of people with type 2 diabetes. The once-weekly injectable, known as CagriSema (KAG-ruh-SEM-uh), was evaluated in three Phase 3 REIMAGINE studies. In people early in the course of type 2 diabetes, researchers reported A1C reductions of up to 1.8 percentage points and significant weight loss compared to placebo after 40 weeks of treatment. Investigators also noted improvements in several cardiometabolic risk factors, including blood pressure. https://www.medpagetoday.com/meetingcoverage/ada/121658 XX Stelo for kids is now FDA cleared.. the over the counter Glucose Biosensor System is now approved for children as young as 2 years old who do not use insulin. The FDA identified pediatric prediabetes as a growing public health concern motivating the expanded indication, noting OTC CGMs can help younger users and their caregivers build glycemic awareness, track patterns in response to me https://www.hcplive.com/view/fda-clears-first-otc-glucose-monitor-for-children XX Insulet presented new data from its STRIVE and EVOLUTION 3 studies showing improved glucose control with its next-generation Omnipod 6. That's , the company's upcoming hybrid closed-loop system for people with type 1 and type 2 diabetes. The main difference between the Omnipod 6 and Insulet's current Omnipod 5 patch pumps is that the new system has a lower glucose target of 100 mg/dL and better Bluetooth connectivity Insulet also shared progress on a fully closed-loop system designed specifically for type 2 diabetes. It  does not require carb-counting or insulin bolusing ahead of meals. Physicians also don't need to program the starting settings.   XX Abbott shared new research highlighting challenges in identifying and managing diabetic ketoacidosis (DKA). The studies coincide with the company's development of Libre Duo, a dual glucose-ketone sensor that continuously tracks both measurements. Abbott reported that DKA can be difficult to recognize when patients first arrive at the hospital, based on data from more than 100,000 people. The company has submitted the dual sensor to the FDA and recently received CE Mark approval in Europe. More news from ADA including info from Dexcom, Sequel, Sensonics and the world loses a tireless T1D advocate.. that's all to come right after this. --   Back to the news.. XX   Dexcom announced its acquisition of Nutrisense, a company that combines continuous glucose monitoring with nutrition coaching and behavioral support. At ADA, the company also presented results from the CONNECT study showing significant A1C reductions and improved glucose control in people with type 2 diabetes not using insulin. The findings add to growing evidence supporting CGM use beyond intensive insulin therapy. We did an episode with CEO Jake Leach at ADA about these announcements as well as updates on G8, their hospital product and much more. XX Sequel Med Tech reported positive clinical results evaluating its twiist automated insulin delivery system in people with type 2 diabetes. The study showed improvements in A1C and time in range over 13 weeks XX Senseonics presented new real-world data supporting the performance of its Eversense 365 implantable CGM. The analysis included more than 12,000 sensors and demonstrated sustained accuracy and effectiveness in both open-loop and automated insulin delivery settings. Researchers also evaluated Eversense use with Sequel Med Tech's twiist system. The findings support broader use of long-term implantable CGM technology.   -- MiniMed used ADA 2026 to spotlight two recently cleared diabetes management systems. The MiniMed Flex pump offers a smaller, smartphone-controlled insulin pump option, while MiniMed Go combines the InPen smart insulin pen with Abbott's Instinct sensor. The products received FDA clearance earlier this year. XX Tandem Diabetes Care highlighted data supporting the use of its Control-IQ automated insulin delivery technology during pregnancy. Results from the CIRCUIT trial showed users spent approximately three additional hours per day in the recommended pregnancy glucose range compared with standard therapy. The findings helped support recent regulatory approvals for pregnancy use in both Europe and the United States. Tandem also expanded indications for adults with type 2 diabetes. XX Beta Bionics presented real-world data from the first three years of iLet Bionic Pancreas use. The company reported a 25% improvement in time in range among users, along with positive feedback from clinicians about simplified diabetes management. The iLet system requires only a user's weight to begin therapy and eliminates carbohydrate counting. Beta Bionics also highlighted growing access to near-real-time outcomes through its public data dashboard. XX MannKind presented new findings supporting its Afrezza inhaled insulin at ADA 2026. A post-hoc analysis of the INHALE-1 study found that pediatric users reported greater treatment satisfaction compared with those using rapid-acting injected insulin. The results come shortly after FDA approval expanded Afrezza's indication to include children. We did a bonus episode with one of the lead investigators of the study that lead to that approval. XX Adaptyx presented early clinical data supporting a wearable sensor that continuously measures cortisol levels. The device successfully tracked cortisol changes during both controlled testing and overnight monitoring in first-in-human studies. Company leaders say cortisol plays a major role in conditions including diabetes, hypertension, and depression. The technology uses synthetic DNA-based molecular switches to generate real-time readings.   XX Biolinq shared new clinical findings for its Shine continuous glucose monitoring system. The needle-free device combines glucose monitoring with activity and sleep tracking .The system received FDA clearance in 2025. They're also looking at measuring lactate through the sensor. XX Long-time T1D advocate Kent Schnakenberg died last week. Schnakenberg was known in his community for using his love of bicycling to raise awareness of Type 1 diabetes. He also advocated for improving the lives of those living with the disease. Inspired by his niece, Michelle, who was diagnosed with juvenile diabetes when she was 13 years old, since 2014 he has traveled around the country cycling thousands of miles, speaking to hundreds and hundreds of kids and raising Money. According to Schnakenberg's family, he suffered a head trauma incident in his home on Wednesday. I spoke to Kent years ago – I believe the first year of the podcast. A sad loss but wonderful to see so many tributes and memories posted on social media in the last few days. https://diabetes-connections.com/john-costik-co-creator-of-nightscout-team-schnak/ https://www.wibw.com/2026/06/12/team-schnak-founder-kent-schnakenberg-passes-away/ XX And finally. Alexander Zverev (ts-ver-uhv) won the French Open, his first Grand Slam title. He lives with type 1, he paused a couple of time to check his blood sugar. He was diagnosed at age 4 and partners with Medtronic. "Becoming a professional tennis player was always my dream," Zverev shared in an article posted by Medtronic. "Early on, I was told that competing at the highest level with diabetes was impossible — but my family and I refused to accept that. That's why I'm partnering with Medtronic Diabetes: I want every person with diabetes to feel empowered to live the life they want." He also has a foundation committed to children with type 1 diabetes. Among other things, the life-saving insulin and other essential drugs are provided – also in developing countries." https://www.mensjournal.com/news/alexander-zverev-diabetes-wins-french-open-2026-medical-condition

 Most people with type 1 diabetes are told: “just have a snack before exercise.” But blood sugars are far more complex than that.I ran a real experiment using a CGM—intentionally spiked my glucose, then brought it back down using exercise. The result? Almost exactly where I started.It's not guesswork. It's timing, volume, and understanding how your body responds. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken sits down with Kelly Schmidt, diabetic dietitian and longtime Type 1 diabetes advocate, to have a deep conversation about one of the biggest topics in diabetes right now:With medications like Ozempic and other GLP-1-based therapies becoming more common, there are a lot of questions:1. Are these just weight-loss medications?2. Can people with Type 1 diabetes benefit from them?3. How do you use them safely?4. What happens with food, muscle, digestion, and long-term health?Kelly shares her personal experience using GLP-1 medications since 2017 and explains why these medications are about much more than weight loss. The conversation explores how GLP-1s impact appetite, digestion, hormones, inflammation, and blood sugar management.Ken and Kelly also discuss the difference between single agonists and dual agonists, why the “strongest” medication is not always the best medication, and why having conversations with your healthcare team is critical when deciding what works for your individual needs. The episode also dives into some of the biggest concerns people with Type 1 diabetes have:Can GLP-1 medications worsen gastroparesis?Do they cause bone loss?How do you protect muscle while using these medications?What role do protein and strength training play?Kelly shares practical guardrails around using these medications, including the importance of adequate nutrition, resistance training, and building systems that support your health—not just chasing a number on the scale.This episode is an honest conversation about a rapidly evolving area of diabetes care and how people with Type 1 diabetes can ask better questions, understand their options, and make informed decisions with their healthcare team.

In this episode of the Building Better Humans Project, I want to challenge the way you think about fun. Most people spend their lives chasing what is known as Type One Fun—the things that are enjoyable in the moment. Good food, comfortable weekends, nights out with friends, holidays, entertainment and all the things that make us feel good right now. But what if the best moments of your life aren't found in comfort? What if the moments that shape you the most are actually the ones that suck while you're doing them? In this episode, I unpack the difference between Type One Fun and Type Two Fun. Type Two Fun is the kind of experience that feels hard, uncomfortable and sometimes downright miserable while you're in it. It's the challenge you almost didn't take on. It's the adventure that pushed you to your limits. It's the difficult conversation, the tough workout, the mountain climb, the business risk, or the moment you chose courage over comfort. I've seen it countless times on the Kokoda Track, on Mount Kilimanjaro and through years of working with people who are trying to become the best version of themselves. The experiences people complain about the most while they're happening often become the stories they treasure the most afterwards. Because growth doesn't live inside your comfort zone. We live in a world that has become obsessed with convenience, comfort and instant gratification. The problem is that comfort rarely changes us. Challenge does. Adversity does. Pushing yourself beyond what you thought was possible does. Throughout this episode, I share some personal stories and lessons from the adventures, challenges and experiences that have taught me this lesson time and time again. More importantly, I challenge you to look at your own life and ask yourself whether you've become too comfortable. If you're looking for more confidence, resilience, growth and fulfilment, the answer may not be found in making life easier. It may be found in deliberately choosing the harder path. The truth is, the best stories of your life are rarely written when everything is easy. They're written when you decide to embrace a little more Type Two Fun. Enjoy the episode. The Building Better Humans Project is brought to you by ADVENTURE PROFESSIONALS. Visit www.adventureprofessionals.com.auADVENTURE WITH GLENN ONLINE MINDSET PROGRAMS 1-ON-1 MENTORINGSee omnystudio.com/listener for privacy information.

Alexis is a Type 1 diabetic mom of three boys from Nevada. Her first birth was a 37-week induction due to her diabetes that ended in a vaginal delivery. For her second birth, Alexis was told she needed a cesarean because her baby was expected to be "massive," but after birth, he was perfectly average-sized. In the OR, her providers admitted their prediction was wrong, and Alexis was devastated. Alexis was determined more than ever to educate herself and advocate hard for her next birth.During her third pregnancy, Alexis navigated polyhydramnios, multiple provider changes, and concerns about possible fetal heart abnormalities that ultimately turned out to be no issue after birth. But even with these challenges, still advocated and achieved her unmedicated VBAC. Her labor ended with a shoulder dystocia with her baby having a broken arm, but with a smooth recovery. Alexis shares how TVL, research, informed decision-making, educating her support team, and using the B.R.A.I.N. acronym helped her throughout her pregnancy and birth journey.Note from Alexis: “There was never a real explanation as to why they suspected he had ARSA, the increased velocity, or the small hole in utero. And as a tip for anyone in labor, honey is considered a clear liquid, and the cheap honey bears at Walmart are great during labor! I took swigs off of it during labor for energy and to keep my blood sugar up. The midwife came to check on me at one point mid-swig and said that was the first time she had seen that in her 25 years. I couldn't find honey sticks locally for a reasonable price, but I could find local honey bears.”Keywords: VBAC, Type 1 diabetes, juvenile diabetes, induction, 37-week induction, scheduled cesarean, suspected macrosomia, big baby, polyhydramnios, unmedicated VBAC, shoulder dystocia, broken humerus, birth injury, fetal heart concerns, ARSA, informed consent, B.R.A.I.N., VBAC prepNatural Birth for Type 1 Diabetics Facebook GroupT1D Pregnancy Course Needed Website: Code TVL for 20% OffThe Ultimate VBAC Prep Course for ParentsOnline VBAC Doula TrainingAdvertising Inquiries: https://redcircle.com/brands

Tyler Cook is a professional GT3 racing driver who has competed in some of the most grueling endurance races on the planet, the 24 Hours of Spa, the 24 Hours of Nürburgring, IMSA, and GT World Challenge Europe. He's also been living with type 1 diabetes since he was 11 years old. This episode gets into what it actually looks like to manage blood sugar in a fire suit, in a 130-degree cockpit, at 150 miles per hour, sometimes at 3 a.m. Tyler takes us back to his diagnosis in 2006 — an ICU stay, four IVs, and a very specific grief over the chocolate mousse at Epcot's France pavilion. From there, he walks us through the journey from go-karts in his dad's garage to GT3 race cars with 650 horsepower. Along the way, there was bullying in middle school over his diet, sneaking to the bathroom to give injections on dates, and a decision somewhere along the line to stop hiding his diabetes and start owning it. We get into the technical side, too: how OmniPod changed his race management strategy, why adrenaline sends his blood sugar climbing instead of crashing, what a 24-hour-race insulin plan actually looks like, and what it means to have a Gatorade button wired into your cockpit as an emergency low-blood-sugar protocol. Tyler also talks about the physical training side of racing — heart rate zone work, neck day (yes, neck day), and why a GT3 driver can be pressing 1,200 pounds of brake force per pedal. The episode wraps with something that's been sitting with both Rob and Tyler: the idea of trusting the process. For Tyler, the lesson comes through racing — you can't skip steps from spec Miata to GT3. For people with T1D, it's the same. Wherever you are in your management journey, that's where you are — and it's going to get better if you just keep going. Chapters: 00:00 Climbing out of a race car at 2 a.m. 00:51 Introducing Tyler Cook, GT3 driver with T1D 01:52 Diagnosis at 11: ICU, four IVs, and Epcot chocolate mousse 04:16 Go-karts at three, racing in the family DNA 06:20 Racing pre-CGM: going off vibes and feeling lows 07:29 Bullied for his diet in middle school 09:53 Dating with diabetes and deciding to stop hiding it 12:29 Going public: from fear of losing opportunities to advocacy 13:35 A potential cure and why staying healthy now matters 17:19 What GT3 racing actually is — and why you should go watch it 23:02 The Gatorade button: CGM and cockpit glucose management 24:28 130-degree cockpits, adrenaline spikes, and pre-race hydration 25:39 WHOOP strain scores: practice vs. race stint 28:37 Training for the car: heart rate zones, neck day, 1,200-lb brakes 36:45 What Tyler would tell 11-year-old himself: trust the process Resources: * Tyler Cooke Instagram * Breakthrough T1D * Conor Daly (T1D IndyCar driver Tyler mentioned)

If you've been working harder and harder to improve your blood sugars but still feel stuck, this message is for you.Many people with Type 1 Diabetes hit a point where more effort doesn't create better results—it only creates more frustration and burnout.The breakthrough often comes from strategy, precision, and understanding what's really holding you back.Remember: Sometimes the hose isn't too short... it's just wrapped around the table.Work smarter, not harder. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken and Graham explore some of the newest innovations and ideas that could shape the future of Type 1 diabetes management.The conversation begins with a discussion around Medtronic's new MiniMed Flex system and what advancements in insulin pump technology could mean for people living with diabetes. Ken and Graham discuss convenience, usability, and the ongoing evolution of automated insulin delivery systems.From there, the conversation shifts into an important discussion around pregnancy and Type 1 diabetes, including the unique challenges women face during pregnancy, the importance of blood sugar management, and how technology can help support both mom and baby throughout the process.The episode wraps up with a fascinating look at the future of diabetes innovation. Ken and Graham discuss emerging technologies, including implantable insulin delivery systems, heat-stable insulin, closed-loop automation, and the ongoing pursuit of better long-term solutions for people living with Type 1 diabetes. While some of these technologies are still years away, the conversation highlights how rapidly the diabetes landscape continues to evolve. Whether you're interested in the latest diabetes technology, planning for pregnancy, or simply curious about where diabetes care is headed, this episode offers an engaging look at what's coming next.

“I had no idea adults could get Type 1”. Sue May spent more than 20 years as a health coach supporting women through fertility, IVF, perimenopause, and menopause. But in her 50s, her own life took an unexpected turn when she was diagnosed with type 1 diabetes after missing symptoms like extreme thirst, rapid weight loss, and exhaustion, eventually discovering her blood sugar was over 500.As someone who had spent her career helping others navigate major health transitions, Sue suddenly found herself overwhelmed, under-supported, and trying to make sense of a diagnosis she never saw coming.In this episode, Sue shares what it was really like to be diagnosed later in life, the emotional weight of learning to manage an entirely new condition, and how finding the right support completely changed her experience. She also opens up about the overlap between type 1 diabetes and perimenopause, why so many women are left without answers during hormonal shifts, and what it looks like to advocate for yourself through seasons of change.Tune in to gain a deeper understanding of adult-onset type 1 diabetes, the impact hormones can have on blood sugars, and the reminder that even the most unexpected diagnosis can become an opportunity to reclaim your rise.WHAT WE COVER:How Sue navigated being diagnosed with T1D in her 50sWhy adult-onset type 1 diabetes is far more common than most people realize, and early signs to watch forWhat it means to stay flexible when life, hormones, and diabetes are constantly evolvingSue's reminder that women are not “crazy” when they notice midlife changesHow Sue turned an unexpected diagnosis into a new purpose and a deeper way of serving othersHow finding community helped her stop feeling alone and start feeling empowered in her diabetes journeyWhy reclaiming your rise starts with putting yourself first and trusting your ability to adapt through every seasonWHAT'S NEXT:

 Living with diabetes doesn't have to mean constant highs, lows, and mental exhaustion.In this conversation, a 25-year T1D shares how she went from 60–70% time in range to 78%—and even 95% on easier days—while actually living her life again.Less stress, more energy, and finally space to just be present. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken and Graham tackle one of the most fascinating and controversial questions in the diabetes world:What will happen first—a cure for Type 1 diabetes or a way to prevent it altogether?The conversation begins with a discussion around continuous glucose monitors, the barriers to bringing new diabetes technology to market, and why FDA approval plays such a significant role in innovation and accessibility.From there, Ken and Graham zoom out to examine diabetes on a global scale. They explore the challenges people with diabetes face in developing countries, the realities of insulin access, and whether advanced technology like CGMs should be prioritized when many people still struggle to obtain life-saving insulin.The discussion then shifts into the future of Type 1 diabetes research, including Teplizumab (Tzield), immunotherapy, stem cell research, autoimmune triggers, and the ongoing debate between prevention and cure.Along the way, Ken shares his perspective on the role that lifestyle factors—including stress, sleep, nutrition, exercise, and overall health—may play in autoimmune conditions, while Graham challenges the conversation by exploring whether vaccines, immunotherapy, or preventative treatments could eventually become the standard approach.This episode is an honest discussion about innovation, skepticism, hope, and the future of diabetes care.

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken sits down with Ryan Bash for a powerful conversation about what it's really like growing up and navigating school with Type 1 diabetes.Ryan shares his experience being diagnosed at a young age and how diabetes has shaped the way he approaches problem-solving, engineering, school, sports, and self-advocacy. What starts as a conversation around math, measurement, and hands-on learning evolves into a much deeper discussion about the real-life challenges kids with diabetes face every single day in school systems that often don't fully understand the condition.Together, Ken and Ryan unpack:how diabetes develops problem-solving skillswhy “if this, then this” thinking becomes second naturethe impact of highs and lows during tests and classnavigating 504 plans and accommodationsdealing with substitute teachers and school policiesadvocating for yourself when adults don't understand diabetesand why blood sugar numbers should never define self-worthRyan also shares several frustrating experiences with teachers and school staff who ignored or misunderstood his diabetes accommodations, leading to a powerful conversation around communication, confidence, and self-advocacy.

What happens when the healthcare professional becomes the parent sitting on the other side of the diagnosis? In this episode, Katie Taylor sits down with Melissa Apa—a clinical pharmacist, diabetes educator, and mom—to share her family's journey navigating both celiac disease and type 1 diabetes with her young son. Melissa opens up about the emotional overwhelm of receiving life-changing diagnoses, even with years of medical expertise behind her, and how her family learned to adapt, advocate, and find stability in the chaos. From replacing every pot and pan in her kitchen overnight to teaching her six-year-old how to manage his insulin pump, Melissa shares the realities of parenting a child with chronic illness while balancing work, marriage, caregiving, and the emotional toll of always being "on." Together, Katie and Melissa explore the invisible mental load medical parents carry, the importance of empowering kids to advocate for themselves, and why support systems matter just as much as medical education. This conversation is honest, practical, and deeply hopeful for any parent navigating a chronic diagnosis with their child. What You'll Hear in This Episode: The unexpected appointment that changed everything with a celiac diagnosis Why Melissa says her entire career prepared her to care for her son The emotional impact of becoming both a healthcare provider and a medical mom How type 1 diabetes and celiac disease are often connected The pressure parents feel around "good" and "bad" numbers in diabetes care Why medical parents need systems, routines, and "go bags" to survive daily life Teaching children to advocate for themselves in school and healthcare settings The realities of never fully stepping away from caregiving responsibilities How Melissa and her husband creatively protect their relationship and mental health Why diabetes management can become more manageable with support and practice Key Takeaways: Chronic illness management is emotional—not just medical Blood sugar numbers are data, not moral judgments Kids are capable of learning and advocating for themselves earlier than we think Systems and routines can reduce overwhelm for families Caregivers deserve support, too The beginning of a diagnosis journey is often the hardest part—but it won't always feel this overwhelming About Our Guest: Melissa Apa is a clinical pharmacist, diabetes educator, podcast host, and mom of two from Buffalo, New York. After diagnosing her son with type 1 diabetes and navigating celiac disease as a family, Melissa shifted her focus toward helping families manage chronic illness with more confidence, support, and sustainable systems. Through coaching, education, and advocacy, she helps parents move from survival mode to feeling empowered in everyday life. Resources & Links: Connect with Melissa on Instagram: @melissaapa_ Listen to her podcast: Insulin Inspired Learn more about Melissa's coaching and resources on her website Connect with Us Subscribe: Never miss an episode on Apple Podcasts or Spotify. Visit insidethechildrenshospital.com to search stories and episodes easily Follow us on Instagram for updates and opportunities to connect with other parents Download SupportSpot: receive Child Life tools at your fingertips. Leave a Review: It helps other families find us and access our resources!   Medical information shared in this episode is not a substitute for professional medical advice. Please consult your care team for guidance specific to your child and family. Keywords: type 1 diabetes, celiac disease, parenting a child with diabetes, diabetes mom, medical parenting, chronic illness parenting, pediatric diabetes, celiac diagnosis, type 1 diabetes support, caregiver mental health, diabetes advocacy, medical mom podcast, child chronic illness support, parenting through diagnosis  

What's next in the attempt to change the course of type 1 diabetes?  SAB Bio says they're looking to redefine what it means to get a type 1 diabetes diagnosis. They're trialing a drug right now preserve the patient's ability to make their own insulin.. and maybe even allow repeat dosing. I'm talking to Dr. Michael Haller from the University of Florida and Sam Reich the CEO of SAB Bio about what makes this different and what their big hopes are. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

In this episode, Meg Bomley shares her T1D journey from being diagnosed at 18 years old and spending eight years on MDI without a CGM, to becoming someone who feels deeply empowered in her body and her diabetes.Meg first came on the podcast in 2022 after graduating from Risely coaching. At the time, she had just come out of a season of constant lows, burnout, and feeling completely overwhelmed after switching to a pump without the support she needed.Today, she's back as a nationally board certified health coach, and 35 weeks pregnant with type 1 diabetes, one of Risely's top coaches.The majority of this conversation is the reality of navigating pregnancy with T1D: the nausea, insulin resistance, fear of highs, changing carb ratios, and learning to trust yourself in this season.WHAT WE COVER:Why Meg resisted pumps and CGMs for nearly 8 years after diagnosisThe “biggest disaster ever” that happened when she first switched to a pumpWhat finally helped her stop feeling resistant, overwhelmed, and burnt out with diabetesHow coaching helped her uncover mindset blocks that had nothing to do with insulin or carb countingThe first sign Meg noticed that told her her insulin resistance was changing after getting pregnantHow she managed nausea, vomiting, insulin on board, and eating mostly carbs during pregnancyThe difference between taking 5 units for oatmeal pre-pregnancy vs. 16 units during pregnancyWhat it's actually like mentally to watch yourself take “large amounts of insulin” every dayWHAT'S NEXT:

Dr. Ian Lake has worked as a doctor in the NHS for nearly four decades, most of this time as a general practitioner. After being diagnosed with LADA Type 1 Diabetes at age 36 and managing it conventionally for 20 years, he adopted the low carb diet and has been following it for the past 10 years. He is a founding member of the Public Health Collaboration in the U.K. and has conducted several important research projects investigating the connection between low carb diets and human health. He has also worked with Dr. Tro and others to produce the Type 1 Consensus Statement. In this episode, Drs. Tro and Ian talk about… (00:00) Intro (03:30) The mental and physical health challenges faced by Type 1 Diabetics and how these challenges have traditionally been dealt with (13:44) Ketoacidosis, what insulin does, and modern methods/dietary reccomendations for controlling Type 1 Diabetes (25:45) How Dr. Lake's colleagues have responded to his ideas regarding Type 1 and ketogenic diets (38:00) Dr. Lake's new book, Shifting Gears, on the need to move from a glucose-centric view of Type 1 to a holistic, healthy human being perspective (50:23) Outro For more information, please see the links below. Thank you for listening! Links: Please consider supporting us on Patreon: https://www.lowcarbmd.com/ Resources Mentioned in this Episode: Dr. Ian Lake's last appearance on the LCMD Podcast: https://lowcarbmd.com/podcast/episode-368-dr-ian-lake/ Dr. Ian Lake: X: https://twitter.com/idlake Type1Keto: https://type1keto.com Type 1 Consensus Statement: https://journalofmetabolichealth.org/index.php/jmh/article/view/100 Case report: Ketogenic diet alleviated anxiety and depression associated with insulin-dependent diabetes management: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1404842/full Shifting Gears (New Book): https://type1keto.com/product/shifting-gears-the-1000-mile-ride-that-changed-my-mindset-on-type-1-diabetes/ Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author Dr. Tro Kalayjian:  Website: https://toward.health Twitter: https://twitter.com/DoctorTro IG: https://www.instagram.com/doctortro/ Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.  Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://toward.health/community/

This is a deep dive on Enneagram Type One. Not the surface level version you have heard a hundred times. We are going into the psychology, the wiring, what is actually happening underneath, and the parts of being a One that almost nobody talks about out loud.In this episode:How Type One is different from Six, Three, and Eight, and the clearest way to tell them apartWhere the anger lives, why it never gets called anger, and what it does to the body when it has nowhere to goThe defense mechanism running quietly underneath everythingWhat this type looks like at every level of awarenessThe thing every One needs to hear, and almost never doesWho this is for: Anyone who suspects they might be a One, anyone who loves a One and wants to understand them more deeply, and any One who is ready to see themselves a little more clearly.If you are still in the process of figuring out your type, the Self-Typing Toolkit is built for you. A nine dollar collection of tools designed to help you find your type through 5 days of guided self-discovery.⁠Get the Self-Typing Toolkit HERE!⁠Connect on ⁠⁠⁠⁠⁠⁠⁠Instagram⁠.Take the Unf*ck Your Type Enneagram shadow work course ⁠⁠⁠here⁠⁠⁠. ⁠Enneagram shirts⁠All of my freebies and links can be found ⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠.Join my free private ⁠⁠⁠⁠⁠⁠⁠Facebook group⁠⁠⁠⁠⁠⁠⁠.

In this episode, Eoin sits down with Steven Cannady (@steven.cannady) to talk about the reality of living with Type 1 Diabetes for the past 21 years.Diagnosed at 13 years old, Steven shares the highs, lows, frustrations, and lessons that have shaped his journey, along with how running became something that gave him purpose, structure, and confidence.We also dive into the challenges of managing blood sugars while training for and completing 7 marathons, building Type 1 Diabetes Dash, and the mindset shifts that helped him stop seeing Diabetes as a limitation.A practical and honest conversation for anyone living with Type 1 Diabetes or trying to take better control of their health.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

From surviving Type 1 diabetes, cancer, amputation, medical malpractice, and near-death experiences to rebuilding her happiness and marriage, Paula Aldis shares a deeply personal story of resilience, faith, and emotional healing. In this episode, Paula opens up about living with chronic illness from childhood, enduring more than 30 surgeries, and navigating years of physical and mental hardship while refusing to lose her identity or hope. https://youtu.be/W9GEKvAdFvw She discusses the emotional toll of constant medical crises, the strain it placed on her family and marriage, and the turning point that inspired her to write her memoir, The Woman Who Wouldn't Quit: Unbreakable Spirit. Paula explains how writing the book became a cathartic process that helped her reclaim her voice, process trauma, and finally move beyond simply surviving. The conversation also explores topics like adoption, parenting children with mental health challenges, PTSD in military families, finding happiness after trauma, and learning to appreciate life's small moments again. Paula's story is a powerful reminder that resilience isn't about pretending to be strong—it's about continuing to move forward, even after unimaginable pain. If you've ever struggled with chronic illness, emotional burnout, family hardship, or finding joy after adversity, this episode will leave you inspired by Paula's honesty, courage, and refusal to quit. Quotes: “Find something that you can do versus what you can't do, and I've had to make that my mental thought. You can still do things.”  “There is getting past the most horrific things that you go through. You can get past it. You have to just get right with yourself first to move on.” “The scars will always be there, but I now see them as reminders of what I have been through. I wear them with pride.”  Contact Details: Follow Paula Aldis on FacebookSubscribe to Author Paula Aldis on YouTubeShop Paula Aldis' Books on AmazonVisit Paula Aldis' Official Website